Wakabayashi Ichiro, Marumo Mikio, Ekawa Kazumi, Daimon Takashi
Department of Environmental and Preventive Medicine, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, 663-8501, Japan.
Department of Biostatistics, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, 663-8501, Japan.
Pract Lab Med. 2024 Feb 16;39:e00376. doi: 10.1016/j.plabm.2024.e00376. eCollection 2024 Mar.
Serum and plasma are used for measurements of microRNAs (miRNAs) as biomarkers of various diseases. However, no consistent findings have been obtained regarding differences in serum and plasma levels of miRNAs. The purpose of this study was to clarify differences in serum and plasma levels of total miRNAs and their time-course changes after blood collection.
Venous blood was collected from healthy men, and samples were prepared at the time points of 0, 15, 30, 60 and 180 min after blood collection for plasma and after clot formation for serum. Levels of total miRNAs were analyzed by the hybridization method using the 3D-Gene miRNA Oligo chip.
About one third of 2632 miRNAs tested showed levels high enough for comparison of serum and plasma levels and for investigation of their time-course changes. Levels of 299 miRNAs at time 0 were significantly different in serum and plasma. Levels of representative platelet-derived miRNAs including miR-185-5p, -22-3p and -320b were significantly higher in plasma than in serum, while levels of representative erythrocyte-derived miRNAs including miR-451a, -486-5p and -92a-3p were not significantly different in serum and plasma. Plasma levels of 173 miRNAs and 6 miRNAs showed significant decreasing and increasing tendencies, respectively, while there were no miRNAs in serum that showed significant time-course changes.
The results suggest that careful attention should be paid when comparing serum and plasma levels of miRNAs and that plasma samples should be prepared early after blood collection.
血清和血浆被用于检测微小RNA(miRNA),作为各种疾病的生物标志物。然而,关于血清和血浆中miRNA水平的差异,尚未获得一致的研究结果。本研究的目的是阐明血清和血浆中总miRNA水平的差异及其采血后的时间进程变化。
采集健康男性的静脉血,分别在采血后0、15、30、60和180分钟制备血浆样本,在血液凝固后制备血清样本。使用3D-Gene miRNA寡核苷酸芯片通过杂交法分析总miRNA水平。
在检测的2632种miRNA中,约三分之一的miRNA水平高到足以比较血清和血浆水平,并研究其时间进程变化。在采血后0分钟时,299种miRNA的血清和血浆水平存在显著差异。包括miR-185-5p、-22-3p和-320b在内的代表性血小板源性miRNA在血浆中的水平显著高于血清,而包括miR-451a、-486-5p和-92a-3p在内的代表性红细胞源性miRNA在血清和血浆中的水平无显著差异。173种miRNA的血浆水平呈显著下降趋势,6种miRNA的血浆水平呈显著上升趋势,而血清中没有miRNA显示出显著的时间进程变化。
结果表明,在比较miRNA的血清和血浆水平时应谨慎,并且应在采血后尽早制备血浆样本。